Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest colitis Stories

2010-10-27 06:30:00

MOUNTAIN VIEW, Calif., Oct. 27 /PRNewswire/ -- ChemoCentryx, Inc., today announced that it reported one-year results from the Company's PROTECT-1 Study (the Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial) of Traficet-EN(TM) (CCX282-B) in patients with moderate-to-severe Crohn's disease. Traficet-EN, an orally bioavailable CCR9-specific chemokine receptor antagonist showed clinical efficacy in a 12-week Induction period, as well as a 36-week Maintenance period....

2010-10-21 00:00:42

The Crohn's & Colitis Foundation today announced that Bob Van Dillen, meteorologist for HLN's "Morning Express with Robin Meade," will again serve as honorary Chairman of its endurance training and fundraising program, Team Challenge (http://www.ccteamchallenge.org). As Honorary Chairman, Van Dillen is training for the December 5th Zappos.com Rock "Ëœn' Roll Las Vegas Half Marathon and raising crucial dollars for the Foundation's research, education, and support services. New...

2010-10-18 16:23:57

In five different studies presented at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, researchers explored the impact of various factors on increasing rates of Clostridium difficile infection (C. difficile), such as the use of proton pump inhibitors (PPIs) and the substantial increase in antibiotic use due to new National Hospital Quality Measures; strategies to combat high rates of C. difficile infections; and cutting"edge...

2010-10-18 16:02:17

Vital that those caring for IBD patients evaluate for vitamin D nutritional deficiency Vitamin D deficiency puts patients with Inflammatory Bowel Disease (IBD) at greater risk of osteoporosis, osteopenia and an overall higher rate of abnormal bone density, according to the results of a new study unveiled today at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, Texas. The study, "Vitamin D Deficiency and Abnormal DEXA Scans in Inflammatory Bowel...

2010-10-15 08:00:00

SKILLMAN, N.J., Oct. 15 /PRNewswire/ -- The Great Comebacks® Program announced today the 2010 regional awards recipients. Now in its 26th year, the annual Great Comebacks® Program recognizes the inspirational achievements of people who have overcome serious intestinal diseases, colorectal cancer and other conditions that can lead to ostomy surgery. (Logo: http://photos.prnewswire.com/prnh/20080227/NYW005LOGO ) (Logo:...

2010-10-14 09:00:00

ATLANTA, Oct. 14 /PRNewswire/ -- UCB, Inc., a global leader in the research and development of medications to treat immunology disorders, today announced the winners of its 2010 UCB Crohn's and Me Scholarship Program for outstanding individuals affected by this condition. UCB has selected 31 winners to receive a scholarship worth up to $10,000 to help them seek personal growth through higher education. The scholarship winners include Crohn's disease patients, as well as family members...

2010-10-12 13:41:23

Researchers at the Georgia Institute of Technology and Emory University have developed a novel approach for delivering small bits of genetic material into the body to improve the treatment of inflammatory bowel diseases. Delivering short strands of RNA into cells has become a popular research area because of its potential therapeutic applications, but how to deliver them into targeted cells in a living organism has been an obstacle. In the Oct. 10 advance online edition of the journal Nature...

2010-10-08 06:30:00

HORSHAM, Pa., Oct. 8 /PRNewswire/ -- People living with ulcerative colitis (UC) say greater understanding is needed about the life-altering nature of this chronic inflammatory bowel disease that affects approximately 500,000 Americans. Data released today from Voices of UC (voicesofuc.com), an initiative developed to educate and raise awareness of the condition, captures the dual perspectives of people who live with the condition and the physicians who treat it. These new survey...

2010-10-05 07:00:00

BURLINGTON, Mass., Oct. 5 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues finds that, in the ulcerative colitis drug market, modest growth of $800 million though 2019 will be driven by the uptake of Abbott/Eisai's Humira, Centocor Ortho Biotech/Merck/Mitsubishi Tanabe Pharma/Janssen's Simponi and Millennium's vedolizumab in the United States, France, Germany, Italy, Spain, United Kingdom and Japan. The...

2010-09-27 05:18:00

UPPER SADDLE RIVER, N.J., Sept. 27 /PRNewswire/ -- WellApps, LLC announced today that it has expanded GI Monitor, its successful (IBD) Crohn's and Colitis symptom tracking application, to Android phones in response to patient demand. GI Monitor is a free symptom tracking service that allows patients to log IBD symptoms such as bowel movements, pain and stress and make correlations with medications and diet. Detailed reports and charts can be printed or emailed to physicians, resulting in...


Latest colitis Reference Libraries

0_9f897835bb09adc2a84fda23893d87f8
2011-04-15 13:50:01

Clostridium difficile, also known as "CDF/cdf", or "C. diff", is a Gram-positive bacteria of the genus Clostridium that causes severe diarrhea and other intestinal disease when competing bacteria in the gut flora are wiped out by antibiotics. They are anaerobic, spore-forming rods and is the most serious cause of antibiotic-associated diarrhea and potentially to pseudomembranous colitis. C. difficile bacteria naturally resides in the gut of a small percentage of the adult population. Others...

More Articles (1 articles) »